PharmaShots

MARCH 9, 2023

Her notable achievements can be attributed to the fact that she has been acclaimed with the Kenneth Rainin Foundation Synergy Award, Robert Wood Johnson Harold Amos Medical Faculty Development Award, Immunology Faculty Mentor of the Year, and Gastroenterology & Hepatology Teaching Award. Present company and time period: Pfizer (2 yrs.)

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

European Pharmaceutical Review

NOVEMBER 10, 2022

Advanced light microscopy techniques can be used to better understand complex medicines and establish new approaches for discovery and development. A new wave of medicines has emerged in recent years to supplement the well-established small and large molecule platforms that have historically dominated the market. Figure 1 ).

Labelling 94

Labelling Compounding 94

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. However, New Science is more expensive to develop. billion and $6.7

Vaccines 90

Vaccines 90

Roots Analysis

AUGUST 28, 2022

Furthermore, several live cell imaging and non-destructive fluorescence histological methods measure limited number of biomarkers at a time and the tags introduced may interfere with the natural function of genes and proteins. 70+ spatial Genomics solutions are developed by industry and non-industry players.

52

52

pharmaphorum

FEBRUARY 26, 2021

However, it wasn’t until 1959 – 73 years and two major acquisitions later – that J&J developed its significant presence in the pharmaceutical industry. Its founder, Dr Paul Janssen, is recognised as one of the most innovative and prolific pharmaceutical researchers of the 20th century. Where it all began.

Vaccines 127

Vaccines Labelling Communication 127

European Pharmaceutical Review

DECEMBER 27, 2023

The first patient ever to receive CAR T-cell treatment (a child with ALL) developed severe life-threatening cytokine release syndrome (CRS) early post CAR T-cell administration and needed intensive care unit (ICU) intervention. Chimeric antigen receptor (CAR) T cells are the first example of a “living drug”.

Adverse Reactions 81

Adverse Reactions Immunization Medical Schools Chemotherapy 81

Pharmaceutical Technology

NOVEMBER 30, 2022

However, there has recently been a boom in interest and research in anti-obesity therapeutics. Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. The UK and US are both undergoing an obesity crisis. were overweight but not obese. million in Q3.

Insurance 105

Insurance Labelling Communication FDA 105

Pharmaceutical Technology

NOVEMBER 30, 2022

However, there has recently been a boom in interest and research in anti-obesity therapeutics. Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. The UK and US are both undergoing an obesity crisis. were overweight but not obese. million in Q3.

Insurance 98

Insurance Labelling Communication FDA 98